Search results
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks· 3 days agoFree Report) issued a statement disagreeing with the ruling by a state court in Delaware to allow jury trials for cases, which claim GSK’s discontinued heartburn drug Zantac ...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated...
Benzinga via Yahoo Finance· 3 days agoOn Sunday, GSK plc (NYSE:GSK) released results from an interim analysis of the DREAMM-8 phase 3...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga via Yahoo Finance· 3 days agoOn Monday, GSK Plc (NYSE:GSK) shares were down after the Delaware State Court ruled that more than...
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session - GSK (NYSE:GSK)
Benzinga· 3 days agoLoading... Loading... U.S. stock futures were mixed this morning, with the Nasdaq futures gaining...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com
Investing.com· 3 days agoShares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow...
GSK Plc ADR (NYSE: GSK): Performance Review And Forecast – Marketing Sentinel
Marketing Sentinel· 3 days agoGSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.67. Most recently the company’s share price was $40.60, and it changed around -$4.17 or -9.31% ...
Bird flu death in Mexico linked to strain not seen in humans before
Seeking Alpha· 13 hours agoThe World Health Organization confirms the first human case of H5N2 bird flu in Mexico. Read more...
Dow Jones Falls As Warren Buffett Stock 'Plunges' 99%; Bill Ackman Makes This IPO Move
Investor's Business Daily· 3 days agoThis was a three-month low. Readings below 50% signal that the manufacturing sector is contracting. ...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg· 3 days agoGSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 3 days agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...